Related references
Note: Only part of the references are listed.Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis
Parag D. Dabir et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? – Somatic mutational profiles vs. ovarian and colorectal carcinomas
Noora K. Porkka et al.
Oncotarget (2020)
The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
N. A. J. Ryan et al.
GENETICS IN MEDICINE (2019)
Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Ryan M. Kahn et al.
CANCER (2019)
EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome
Sagar J. Pathak et al.
HUMAN MUTATION (2019)
Tobacco-specific nitrosamines: A literature review
Evangelia Konstantinou et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome
Rish K. Pai et al.
MODERN PATHOLOGY (2018)
Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
Deepak B. Vangala et al.
EUROPEAN JOURNAL OF CANCER (2018)
Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion
Shigeki Sekine et al.
HISTOPATHOLOGY (2017)
Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis
Shigeki Sekine et al.
MODERN PATHOLOGY (2017)
The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing
E. Ryan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Lynch syndrome in the 21st century: clinical perspectives
A. K. Tiwari et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
Jung Ho Kim et al.
ONCOTARGET (2016)
Prevalence of altered mismatch repair protein nuclear expression detected by immunohistochemistry on adenomas with high-grade dysplasia and features associated with this risk in a population-based study
Marta Basterra et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2016)
Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients
Masahiro Tanaka et al.
HISTOPATHOLOGY (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas
Satu Valo et al.
CLINICAL EPIGENETICS (2015)
Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case
Jinru Shia et al.
FAMILIAL CANCER (2015)
Milestones of Lynch syndrome: 1895-2015
Henry T. Lynch et al.
NATURE REVIEWS CANCER (2015)
Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Francis M. Giardiello et al.
GASTROENTEROLOGY (2014)
Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome
Eva Musulen et al.
HUMAN PATHOLOGY (2014)
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
Bryony A. Thompson et al.
NATURE GENETICS (2014)
EPCAM germline and somatic rearrangements in lynch syndrome: identification of a novel 3′EPCAM deletion
Marijke Spaepen et al.
GENES CHROMOSOMES & CANCER (2013)
Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification
Eva Musulen et al.
HUMAN PATHOLOGY (2013)
Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps
Matthew B. Yurgelun et al.
CANCER PREVENTION RESEARCH (2012)
Colon-specific phenotype in Lynch syndrome associated with EPCAM deletion
P. Grandval et al.
CLINICAL GENETICS (2012)
Yield of routine molecular analyses in colorectal cancer patients=70 years to detect underlying Lynch syndrome
Margot G. F. van Lier et al.
JOURNAL OF PATHOLOGY (2012)
Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry
Michael D. Walsh et al.
MODERN PATHOLOGY (2012)
The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors
Cathrin Huth et al.
MODERN PATHOLOGY (2012)
Frequency of Rearrangements in Lynch Syndrome Cases Associated With MSH2: Characterization of a New Deletion Involving both EPCAM and the 5′ Part of MSH2
Lucia Perez-Cabornero et al.
CANCER PREVENTION RESEARCH (2011)
Analysis of EPCAM Protein Expression in Diagnostics of Lynch Syndrome
Matthias Kloor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
Gilbert Spizzo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
Kandelaria Rumilla et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Marlies J. E. Kempers et al.
LANCET ONCOLOGY (2011)
EPCAM deletions, Lynch syndrome, and cancer risk
Henry T. Lynch et al.
LANCET ONCOLOGY (2011)
Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers
Takeshi Nagasaka et al.
CANCER RESEARCH (2010)
Hereditary and Familial Colon Cancer
Kory W. Jasperson et al.
GASTROENTEROLOGY (2010)
Germline Hypermethylation of MLH1 and EPCAM Deletions Are a Frequent Cause of Lynch Syndrome
Renee C. Niessen et al.
GENES CHROMOSOMES & CANCER (2009)
In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response
Tineke W. H. Meijer et al.
HISTOPATHOLOGY (2009)
Deletions Removing the Last Exon of TACSTD1 Constitute a Distinct Class of Mutations Predisposing to Lynch Syndrome
Marietta E. Kovacs et al.
HUMAN MUTATION (2009)
Deficient DNA Mismatch Repair Is Common in Lynch Syndrome-Associated Colorectal Adenomas
Maria Simona Pino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
EpCAM expression in normal, non-pathological tissues
Eva Schmelzer et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Identification of EpCAM as the gene for congenital tufting enteropathy
Mamata Sivagnanam et al.
GASTROENTEROLOGY (2008)
Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer
B Halvarsson et al.
MODERN PATHOLOGY (2005)
Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection -: Correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis
G Giuffrè et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC
AE De Jong et al.
GASTROENTEROLOGY (2004)
DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer
H Iino et al.
GUT (2000)
Share Paper
